|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.360 CAD | -2.02% |
|
-2.46% | -9.54% |
| 05-15 | HLS Therapeutics Inc., Q1 2026 Earnings Call, May 15, 2026 | |
| 05-15 | HLS Therapeutics Q1 Net Loss Narrows on Lower Costs, Higher Revenue | MT |
| Market Cap | 97.67M 84.35M 77.73M 72.76M 136M 9.28B 138M 918M 358M 4.52B 367M 359M 15.65B | P/E Ratio 2026 * |
-15.6x | P/E Ratio 2027 * | -104x |
|---|---|---|---|---|---|
| Enterprise Value | 97.67M 84.35M 77.73M 72.76M 136M 9.28B 138M 918M 358M 4.52B 367M 359M 15.65B | EV / Sales 2026 * |
1.68x | EV / Sales 2027 * | 1.52x |
| Free-Float |
99.48% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: HLS Therapeutics Inc.
| 1 day | -2.02% | ||
| 1 week | -2.46% | ||
| Current month | -5.01% | ||
| 1 month | -7.04% | ||
| 3 months | -0.91% | ||
| 6 months | -12.63% | ||
| Current year | -9.54% |
| 1 week | 4.28 |  | 4.45 |
| 1 month | 4.28 | | 4.69 |
| Current year | 4.22 | | 4.89 |
| 1 year | 4.22 | | 5.76 |
| 3 years | 3 | | 7.12 |
| 5 years | 3 | | 20.52 |
| 10 years | 3 | | 25.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Millian
CEO | Chief Executive Officer | 58 | 2023-04-30 |
John Hanna
DFI | Director of Finance/CFO | 61 | 2024-01-25 |
Ryan Lennox
CMP | Compliance Officer | 45 | 2018-05-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Rodney Hill
BRD | Director/Board Member | 58 | 2018-03-11 |
John Welborn
CHM | Chairman | 48 | 2023-06-21 |
Norma Beauchamp
BRD | Director/Board Member | 65 | 2020-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-01 | Option | Chairman | 13,120 | 0.0420% | ||
| 04-01 | Option | Director | 3,976 | 0.0127% | ||
| 04-01 | Option | Director | 8,548 | 0.0273% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.02% | -2.46% | -11.02% | -30.13% | 97.67M | |
| -0.40% | +1.08% | +7.67% | +97.49% | 91.79B | |
| +1.22% | +8.82% | +38.68% | +154.32% | 52.43B | |
| -1.86% | -9.59% | -18.77% | +214.29% | 21.42B | |
| +0.62% | +0.49% | -10.95% | -25.32% | 8.13B | |
| -0.07% | +2.43% | -34.66% | -28.05% | 7.54B | |
| +1.19% | -1.22% | -11.46% | -36.80% | 6.77B | |
| -2.80% | -2.46% | +11.48% | +21.79% | 6.49B | |
| +0.30% | +1.01% | -0.93% | +17.66% | 5.32B | |
| +1.27% | -3.62% | -11.95% | -14.53% | 3.53B | |
| Average | -0.25% | +0.60% | -4.19% | +37.07% | 20.35B | |
| Weighted average by Cap. | -0.06% | +3.44% | +9.48% | +103.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 58.03M 50.12M 46.19M 43.23M 81.02M 5.52B 82.27M 545M 213M 2.68B 218M 213M 9.3B | 64.31M 55.55M 51.19M 47.91M 89.79M 6.11B 91.18M 604M 236M 2.98B 241M 236M 10.3B |
| Net income | -6.26M -5.41M -4.99M -4.67M -8.75M -595M -8.88M -58.87M -22.95M -290M -23.51M -23.01M -1B | -1.05M -907K -836K -782K -1.47M -99.8M -1.49M -9.87M -3.85M -48.58M -3.94M -3.86M -168M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 4.360 $ | -2.02% | 6,627 |
| 26-06-11 | 4.450 $ | +2.30% | 27,407 |
| 26-06-10 | 4.350 $ | 0.00% | 5,160 |
| 26-06-09 | 4.350 $ | -1.36% | 210 |
| 26-06-08 | 4.410 $ | -1.34% | 3,010 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HLS Stock
Select your edition
All financial news and data tailored to specific country editions
